Literature DB >> 26631314

Cytotoxicity of electrophilic iron(II)-clathrochelates in human promyelocytic leukemia cell line.

Jenny Blechinger1, Oleg A Varzackii2, Vladyslava Kovalska3, Genrikh E Zelinskii4, Yan Z Voloshin4, Elisa Kinski1, Andriy Mokhir1.   

Abstract

We observed that electrophilic iron(II)-clathrochelates exhibit significant cytotoxicity in human promyelocytic leukemia cells (IC50=6.5±4.6μM), which correlates with the enhancement of intracellular oxidative stress (17-fold increase with respect to the cells treated with the solvent only). Based on in vitro studies we suggested that this effect is caused by alkylation of glutathione leading to inhibition of the cellular antioxidative system and by catalytic generation of reactive oxygen species by products of the alkylation reaction.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alkylation; Cancer; Clathrochelate; Glutathione; Iron

Mesh:

Substances:

Year:  2015        PMID: 26631314     DOI: 10.1016/j.bmcl.2015.11.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Synthesis and spectral characterization of the first fluorescein-tagged iron(ii) clathrochelates, their supramolecular interactions with globular proteins, and cellular uptake.

Authors:  Roman O Selin; Insa Klemt; Viktor Ya Chernii; Mykhaylo Yu Losytskyy; Svitlana Chernii; Andrzej Mular; Elzbieta Gumienna-Kontecka; Vladyslava B Kovalska; Yan Z Voloshin; Anna V Vologzhanina; Pavel V Dorovatovskii; Andriy Mokhir
Journal:  RSC Adv       Date:  2021-02-22       Impact factor: 3.361

2.  Extension and functionalization of an encapsulating macrobicyclic ligand using palladium-catalyzed Suzuki-Miyaura and Sonogashira reactions of iron(ii) dihalogenoclathrochelates with inherent halogen substituents.

Authors:  Irina N Denisenko; Oleg A Varzatskii; Roman A Selin; Alexander S Belov; Ekaterina G Lebed; Anna V Vologzhanina; Yan V Zubavichus; Yan Z Voloshin
Journal:  RSC Adv       Date:  2018-04-11       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.